Table 2.
β2 protein expression by region and genotype using mAb 270
Brain Region | WT fmol/mg wet wt | HT fmol/mg wet wt | MT fmol/mg wet wt | ANOVA Results |
---|---|---|---|---|
Cortex | 1.02 ± 0.29 | 0.78 ± 0.18 | 0.56 ± 0.31 | F2,9=0.75. p=0.50 |
Frontal cortex | 1.38 ± 0.20 | 1.05 ± 0.20 | 0.86 ± 0.26 | F2,9=1.47, p=0.28 |
Olfactory bulbs | 0.66 ± 0.16 | 0.43 ± 0.16 | 0.49 ± 0.08 | F2,9=0.74, p=0.50 |
Interpeduncular nucleus | 4.56 ± 0.69 | 4.80 ± 0.33 | 4.07 ± 0.78 | F2,9=0.35, p=0.72 |
Olfactory tubercles | 0.76 ± 0.20 | 0.78 ± 0.20 | 0.46 ± 0.12 | F2,9=1.02, p=0.40 |
Striatum | 1.65 ± 0.23 | 1.50 ± 0.20 | 1.27 ± 0.21 | F2,9=0.80, p=0.48 |
Medial geniculate | 2.82 ± 0.18 | 3.40 ± 0.22 | 2.32 ± 0.30 | F2,9=5.09, p=0.03* |
Dorsolateral geniculate | 4.77 ± 0.59 | 4.63 ± 0.33 | 3.50 ± 0.61 | F2,9=1.76, p=0.23 |
Ventrolateral geniculate | 3.72 ± 0.22 | 4.15 ± 0.33 | 3.24 ± 0.33 | F2,9=2.36, p=0.15 |
Superior colliculus, optic nerve layer | 3.00 ± 0.46 | 3.84 ± 0.39 | 3.42 ± 0.68 | F2,9=0.10, p=0.90 |
Superior colliculus, superficial gray | 3.72 ± 0.54 | 4.90 ± 0.54 | 4.32 ± 0.78 | F2,9=0.88, p=0.45 |
Inferior colliculus, dorsal cortex | 1.11 ± 0.15 | 1.56 ± 0.32 | 1.37 ± 0.46 | F2,9=0.43, p=0.67 |
Thalamus | 2.49 ± 0.36 | 2.93 ± 0.21 | 2.29 ± 0.33 | F2,9=1.20, p=0.35 |
Thalamus, anteroventral nucleus | 2.82 ± 0.26 | 2.95 ± 0.12 | 2.06 ± 0.37 | F2,9=3.17, p=0.09 |
Trigeminal nucleus | 1.91 ± 0.45 | 1.75 ± 0.12 | 1.45 ± 0.23 | F2,9=0.60, p=0.57 |
Medial ventricular nucleus | 1.03 ± 0.25 | 1.07 ± 0.20 | 0.87 ± 0.15 | F2,9=0.27, p=0.77 |
β2 nAChR subunit protein levels were measured with binding of [125I]-mAb 270 as described in Methods. Binding was quantitated using [125I]-standards of known activity and expressed as fmol/mg wet wt based on specific activity of the [125I]-mAb 270. Results are the mean ± SEM from four individual mice per genotype. Regions with significant differences by one-way ANOVA are shown in bold type.